Navigation Links
IRIDEX Announces Fourth Quarter and Full Year 2007 Conference Call and Release Date
Date:3/28/2008

MOUNTAIN VIEW, Calif., March 28 /PRNewswire-FirstCall/ -- IRIDEX Corporation (Nasdaq: IRIX) today announced that it will release its fourth quarter and full year 2007 financial results after the market closes on Thursday, April 10, 2008. In conjunction with the release, the Company will host a conference call with the investment community at 5:00 p.m. Eastern Time on Thursday, April 10, 2008 to discuss the results of the quarter and other business developments.

Interested parties may access the live conference call via telephone by dialing (800) 240-7305 (US) or (303) 262-2130 (International), or by visiting the Company's website at http://www.iridex.com. A telephone replay will be available beginning on Thursday, April 10, 2008 through Thursday, April 17, 2008 by dialing (800) 405-2236 (US) or (303) 590-3000 (International) and entering Passcode 11111765#.

About IRIDEX

IRIDEX Corporation is a leading worldwide provider of therapeutic based laser systems, disposable laser probes and delivery devices to treat eye diseases in ophthalmology and skin disorders in the aesthetics market. IRIDEX products are sold in the United States through a direct sales force and internationally through a combination of a direct sales force and a network of approximately 100 independent distributors into 107 countries. For further information, visit the Company's website at http://www.iridex.com.


'/>"/>
SOURCE IRIDEX Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. IRIDEX Reports Third Quarter Financial Results
2. IRIDEX Announces Third Quarter 2007 Conference Call and Release Date
3. Theodore A. Boutacoff Appointed President & CEO of IRIDEX
4. James B. Hawkins Appointed to IRIDEX Board of Directors
5. IRIDEX Appoints Burr, Pilger & Mayer New Independent Auditor
6. William Moore Appointed to IRIDEX Board of Directors
7. IRIDEX Announces Closing of $5.0 Million Private Placement
8. China Yingxia International Announces Soybean Milk Production Lines Acquisition
9. Barr Announces Reorganization of Senior Management, Business Functions
10. U.S.News & World Report Announces the 2009 Publication of Americas Best Graduate Schools
11. CVCTA Education Announces New LOW DOSE Initiative for CT Angiograms
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/20/2017)... ... September 20, 2017 , ... Recognising that in ... from Leany Greeny delivers positive results in just three weeks. Setting the groundwork ... the metabolism. Fitting seamlessly into hectic work and family schedules, participants can lose ...
(Date:9/20/2017)... ... ... “Finn Mouseson”: follows the exciting story of a mouse as the need for adventure ... journey that will show that friends are to be gathered but home is always ... Melody Gersonde-Mickelson, who has earned a bachelor’s degree in Fine Arts from the University ...
(Date:9/20/2017)... ... 2017 , ... “Psalms of Humidity”: is a fascinating depiction of daily struggles ... one step closer to God. “Psalms of Humidity” is the creation of published author, ... made within his life are the very same things that have shaped him into ...
(Date:9/20/2017)... ... 20, 2017 , ... “They Sang At Her Funeral”: a tale of murder ... the skeletons in their closets. “They Sang At Her Funeral” is the creation of ... and married with five children and twelve grandchildren. Before becoming a writer, Annalise had ...
(Date:9/19/2017)... ... September 19, 2017 , ... Only a few physicians were ... Brevard’s own Ross A. Clevens, MD, FACS . The founder and medical director ... and Reconstructive Surgeon who trained at Yale, Harvard and the University of Michigan. He ...
Breaking Medicine News(10 mins):
(Date:9/13/2017)... 2017   OrthoAtlanta has been named the official ... Committee (AFHC) for the 2018 College Football Playoff (CFP) National ... Mercedes-Benz Stadium in Atlanta, Georgia . OrthoAtlanta ... In" campaign, participating in many activities leading up to, and ... ...
(Date:9/12/2017)... 2017  ValGenesis Inc., the global leader in ... to announce the appointment of Dr. Ajaz ... of Directors and Chairman of Advisory Board beginning ... companies to manage their entire validation lifecycle process ... this process. Furthermore, ValGenesis VLMS enables rigorous compliance, ...
(Date:9/9/2017)... -- Eli Lilly and Company (NYSE: LLY ) ... lasmiditan, an investigational, oral, first-in-class molecule for the acute ... to placebo in the Phase 3 SPARTAN study. Detailed ... of the International Headache Society (IHC) in ... demonstrate lasmiditan,s potential to reduce pain and provide freedom ...
Breaking Medicine Technology: